Skip to content
Biodatica
Start free

Investigator

Weston W Porter

TEXAS A&M AGRILIFE RESEARCH · funded by NIEHS, NICHD

Companies
1

Resolved onto their grants.

Grants
6

Federal awards on file.

Non-dilutive funding
$3.9M

Summed across those awards.

First award
May 1, 2019

Latest Mar 18, 2022.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Circadian Regulation of Cellular Homeostasis

    $504k

    Mar 18, 2022NIEHSTEXAS A&M AGRILIFE RESEARCHNIH RePORTER · 11252607 (opens the source filing in a new tab)

  2. R01

    Mitophagy Dependent Regulation of Mammary Gland Differentiation

    $420k

    Sep 1, 2021NICHDTEXAS A&M AGRILIFE RESEARCHNIH RePORTER · 11159627 (opens the source filing in a new tab)

  3. P30

    Texas A&M Center for Environmental Health Research (TiCER)

    $1.2M

    May 1, 2019NIEHSTEXAS A&M UNIVERSITYNIH RePORTER · 11122168 (opens the source filing in a new tab)

  4. P30

    Texas A&M Center for Environmental Health Research (TiCER)

    $246k

    May 1, 2019NIEHSTEXAS A&M UNIVERSITYNIH RePORTER · 11122169 (opens the source filing in a new tab)

  5. P30

    Texas A&M Center for Environmental Health Research (TiCER)

    $1.3M

    May 1, 2019NIEHSTEXAS A&M UNIVERSITYNIH RePORTER · 11398558 (opens the source filing in a new tab)

  6. P30

    Texas A&M Center for Environmental Health Research (TiCER)

    $193k

    May 1, 2019NIEHSTEXAS A&M UNIVERSITYNIH RePORTER · 11398560 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources